|
Track I |
Cellular Defenses and Restriction Factors
Cellular Co-Factors for Virus Replication
RNA Packaging, Reverse Transcription and Integration
RNA Interference Studies
Tropism: Receptors/Co-Receptors
Viral Reservoirs: Monocytes/Macrophages
Neuropathogenesis: Virology and Immunology
Innate Immunity in HIV Infection
HIV-1 Specific Humoral Immune Responses
Miscellaneous Immunological Observations
Vaccines: Preclinical Studies
|
Vif and APOBEC3G: Mechanisms of Action <also a Poster Discussion on Monday>
Viral Transcription and Transactivation
Viral Fitness, Evolution and Recombination, and Gag Processing
Mechanisms of Pathogenic and Nonpathogenic Infection
Virus Transmission and Evolution
Neuropathogenesis: Biomarkers and Gene Polymorphisms <also a Poster Discussion on Wednesday>
Population Based Detection Strategies for Acute HIV-1 Infection
Molecular and Immunopathogenesis of Acute HIV Infection
Acute HIV Infection: Natural History and Clinical Observations
Therapeutic Interventions in Acute HIV Infection
Critical Factors in Immune Reconstitution |
Viral Envelope: Tropism and Transinfection
Viral Accessory Genes
Cellular and Innate Immune Reponses
Host Cell Activation: Impact on Replication
Impact of Antiretroviral Therapy on Virus and Host
Molecular Epidemiology
Neuropathogenesis: Clinical Correlates and Observational Studies
Neuropathogenesis: Therapy and Clinical Studies
Role of CD4+ T-Cell Response in Viral Control
Role of CD8+ CTL Response in Control of HIV Infection |
|
Tracks II & IV |
HIV Vaccines: Clinical Trials and Mathematical Models of Efficacy
New Antiretroviral Agents and Approaches – Preclinical Studies
New Antiretroviral Agents and Approaches - Clinical Studies
Implementation of Antiretroviral Access Programs in Resource-Limited Settings
Complex Drug Interactions <also a Poster Discussion on Wednesday>
Mechanisms of Drug Resistance: Entry Inhibitors
Mechanisms of Drug Resistance: Reverse Transcriptase Inhibitors
Mechanisms of Drug Resistance: Protease Inhibitors
Biological Determinants of Disease Progression and Long-Term Outcomes of Antiretroviral Therapy in Children and Adolescents
Pediatrics: Pharmacogenomics and Pharmacokinetic Studies
Pediatric Antiretroviral Therapy in Resource-Limited Settings
Pregnancy: HIV Progression and Treatment Response
Pharmacokinetics of Antiretroviral Drugs in Pregnant Women and Infants <also a Poster Discussion on Tuesday>
Adverse Events in Pregnancy
Incidence and Risk Factors for Cardiovascular Disease
Opportunistic Infections: Risk Factors, Immune Reconstitution and Co-Infection in the Era of HAART
Sexually-Transmitted Infections
Cancer Risk and Incidence
Castleman Disease
Hepatitis B Infection
Hepatitis, HAART and the Liver |
Therapeutic Vaccination
Miscellaneous Immune-Based Therapeutic Approaches to HIV Infection
New Antiretroviral Therapy: Randomized Trials, Strategies and Long-Term Outcomes
Monitoring Immunologic and Virologic Responses to Antiretroviral Therapy in Resource-Limited Settings
Antiretroviral Therapy in Resource-Limited Settings: Safety and Outcomes <also a Poster Discussion on Monday>
Clinical Pharmacology of Nucleoside Reverse Transcriptase Inhibitors
Clinical Pharmacology of Non-Nucleoside Reverse Transcriptase Inhibitors
Clinical Pharmacology of Protease Inhibitors
Clinical Pharmacology of Other Drug Classes
Impact of Resistance on Treatment Response
Interpretation of Drug Resistance Tests
Molecular Diagnostics
Dyslipidemia and Cardiovascular Risk in Pediatric Populations
Lipodystrophy and Other Metabolic Complications in Pediatric Populations
Infectious and Organ System Complications of HIV Disease in Children
Antiretroviral Therapy to Prevent Mother-to-Child Transmission
Factors Influencing Mother-to-Child Transmission
Breast Milk Transmission and Characterization
HIV Infection in Women/Women’s Health
Genomic Mechanisms of Metabolic Complications <also a Poster Discussion on Monday>
Antiretroviral Drug Toxicities and Other Systemic Complications of HIV Disease
KSHV and Kaposi's Sarcoma: Pathogenesis, Epidemiology and Treatment
AIDS Lymphomas: Pathogenesis, Treatment and Outcomes
Immunopathogenesis of Hepatitis C Infection
Therapy of Hepatitis C Infection |
Antiretroviral Therapy: Adherence, Health Care Costs and Access
Adherence to Antiretroviral Therapy and Impact on Outcomes in Resource-Limited Settings
Adverse Effects and Mortality Outcomes of Antiretroviral Therapy in Resource-Limited Settings
Drug Transporters
Therapeutic Drug Monitoring
Selection, Evolution and Persistence of Drug Resistance
Interplay among HIV Resistance, Fitness and Outcome
Epidemiology and Transmission of Resistance
Diagnostics: Co-Receptor Expression and Categorization
Serologic Diagnostics and Quality Control of CD4 Cell Quantification
Pediatric Immunology
Childhood Vaccines
HIV Testing in Labor and in Infants
Antiretroviral Resistance in Mother-to-Child Transmission
Metabolic Syndrome and Other Abnormalities of Fat, Lipid, Glucose and Bone Metabolism
Tenofovir-Associated Renal Dysfunction <also a Poster Discussion on Tuesday>
Treatment Issues in Tuberculosis and HIV Co-Infection <also a Poster Discussion on Tuesday>
Hepatitis C: Epidemiology and Transmission
Morbidity and Mortality from Hepatitis C in the HIV-Infected Population
Hepatitis C: Barriers to Care |
